PMC:7461420 / 98858-99198
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T485 | 40-44 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T486 | 50-83 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T487 | 132-136 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T488 | 220-228 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1107 | 175-176 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T761 | 96-107 | Chemical | denotes | Chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T762 | 259-263 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T763 | 273-277 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T764 | 328-338 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T132 | 143-160 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T133 | 143-160 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3031 | 40-48 | Species | denotes | SARS‐CoV | Tax:694009 |
| 3032 | 18-29 | Species | denotes | respiratory | Tax:12814 |
| 3038 | 132-142 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 3039 | 229-237 | Species | denotes | patients | Tax:9606 |
| 3040 | 96-107 | Chemical | denotes | Chloroquine | MESH:D002738 |
| 3041 | 220-228 | Disease | denotes | COVID‐19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T876 | 0-340 | Sentence | denotes | MERS, Middle East respiratory syndrome; SARS‐CoV, severe acute respiratory syndrome coronavirus Chloroquine (8) was able to inhibit SARS‐CoV‐2 viral replication in vitro, but a recent study found no clinical benefit for COVID‐19 patients who had received the drug 82 (the drug is discussed in detail in the section viral entry inhibitors). |